Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Chemligand Bio-pharmaceutical is a contract research organization (CRO) based in Wuhan, China, specializing in medicinal chemistry and small molecule drug discovery services. The company provides a comprehensive suite of services including custom synthesis, lead optimization, and the development of novel chemical building blocks and scaffolds. With a focus on high-end synthetic chemistry, Chemligand supports international pharmaceutical and biotechnology companies in their R&D efforts across various therapeutic areas such as oncology and metabolic diseases. Their facilities in the Wuhan Optics Valley are equipped for complex multi-step synthesis and process research. The firm is recognized for its expertise in creating novel chemical libraries and providing high-quality intermediates for drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Chemligand Bio-pharmaceutical.